UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: ITZactavis-100mg-Cap-SE-IS-RA

Generated Narrative: RegulatedAuthorization ITZactavis-100mg-Cap-SE-IS-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/20352

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000064-00020352,http://ema.europa.eu/fhir/eurdId#1798; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Capsule, hard; indication = Behandling av följande svampinfektioner, som verifierats genom direkmikroskopi och/eller odling, då systembehandling anses nödvändig: Candidavaginit, oral candidiasis, pityriasis versicolor, svampinfektioner i hud och naglar. Officiella riktlinjer för användning av antimykotika bör beaktas.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = J02AC02

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2005-07-01

holder: Organization Actavis Group PTC ehf.

Cases

-TypeDate[x]
*First Authorisation2005-07-01